1st Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$400,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892 / H.R. 4408, Opioid Addiction Prevention Act of 2017; HR 3528 / S.2460, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act; H.R. 4236, MONITOR Act of 2017; H.R. 3991, Expanded Access to Opioid Abuse Treatment Act of 2017; H.R. 4275, Empowering Pharmacists in the Fight Against Opioid Abuse Act H.R. 5219, Opioid Prescription Verification Act of 2018 Draft legislation on suspension of payments for pharmacies suspected of fraud in Medicare Part D Draft legislation, Medicare Care Coordination Improvement Act of 2017 Draft legislation, Pain Care Coordination Act of 2018 S. 2456/H.R. 5311, CARA 2.0 Act of 2018 Discussion Draft of H.R. __, FDA Packaging and Disposal H.R. 5202, Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Centers For Medicare and Medicaid Services (CMS); Substance Abuse & Mental Health Services Administration (SAMHSA); Agriculture, Dept of (USDA); Office of Personnel Management (OPM); Defense, Dept of (DOD); Office of Natl Drug Control Policy (NDCP); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE; Drug Enforcement Administration (DEA); Government Accountability Office (GAO); White House Office; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 581 (115th), H.R. 1271 (115th), H.R. 4408 (115th), H.R. 5311 (115th), H.R. 1854 (115th), H.R. 3991 (115th), H.R. 5219 (115th), H.R. 5202 (115th), H.R. 3545 (115th), H.R. 3528 (115th), S. 1850 (115th), H.R. 4275 (115th), S. 2460 (115th), S. 523 (115th), H.R. 4236 (115th), S. 2456 (115th), H.R. 1375 (115th), S. 778 (115th)

Health Issues HCR

S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Personnel Management (OPM); Defense, Dept of (DOD); White House Office; Drug Enforcement Administration (DEA); Substance Abuse & Mental Health Services Administration (SAMHSA); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Office of Natl Drug Control Policy (NDCP); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 1776 (115th), S. 771 (115th), H.R. 242 (115th), S. 469 (115th), S. 41 (115th), H.R. 1245 (115th)

Medicare/Medicaid MMM

H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017; Centers for Medicare and Medicaid Services (CMS) Proposed Rule for the 2019 Medicare Part D Plan Year, pharmacy provisions; S.2553, Know the Lowest Price Act of 2018; S.2554, Patient Right to Know Drug Prices Act; H.R. 5343, Prescription Transparency Act of 2018; Discussion draft, requiring plan sponsors to pass on revenue received from certain payments and adjustments to Medicare Part D enrollees; CMS Call Letter for 2019 Medicare Part D and Medicare Advantage Plans

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); Government Accountability Office (GAO); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); White House Office; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA)

Bills named: S. 2553 (115th), H.R. 592 (115th), S. 870 (115th), H.R. 3271 (115th), S. 109 (115th), H.R. 5343 (115th), H.R. 1316 (115th), S. 637 (115th), S. 2554 (115th), H.R. 1038 (115th), H.R. 3921 (115th), H.R. 394 (115th), H.R. 1939 (115th), S. 413 (115th)

Defense DEF

Tricare pharmacy working group

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Office of Personnel Management (OPM); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Defense, Dept of (DOD); Health Resources & Services Administration (HRSA); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); White House Office; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); SENATE; HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC)

Budget/Appropriations BUD

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Agriculture, Dept of (USDA); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Defense, Dept of (DOD); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); White House Office; Health Resources & Services Administration (HRSA)

Bills named: S. 934 (115th), H.R. 2430 (115th)

Animals ANI

Issues related to compounded pharmaceuticals for animals; H.R. 623, FairnesstoPetOwnersActof 2017

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); SENATE; Office of Personnel Management (OPM); Office of Natl Drug Control Policy (NDCP); Health Resources & Services Administration (HRSA); Defense, Dept of (DOD); White House Office; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Bills named: H.R. 623 (115th)

Pharmacy PHA

Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; HR 749, Lower Drug Costs through Competition Act

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Government Accountability Office (GAO); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); SENATE; Medicare Payment Advisory Commission (MedPAC); White House Office; Food & Drug Administration (FDA)

Bills named: H.R. 2871 (115th), H.R. 421 (115th), H.R. 749 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.